Luke Seikkula
Chief Operating Officer presso LA JOLLA PHARMACEUTICAL COMPANY
Profilo
Currently, Luke Seikkula is Senior Vice President-Pharmaceutical Operations at La Jolla Pharmaceutical Co.
He previously was Materials Manager-Ambulatory Infusion Systems at Abbott Laboratories, Senior Director-Materials & Logistics at Spectrum Pharmaceuticals, Inc. and Senior Director-Materials & Logistics at Allos Therapeutics, Inc. (a subsidiary of Spectrum Pharmaceuticals, Inc.) and Vice President-Manufacturing at La Jolla Pharmaceutical Co.
Mr. Seikkula received an undergraduate degree from Winona State University and an MBA from San Diego State University.
Posizioni attive di Luke Seikkula
Società | Posizione | Inizio |
---|---|---|
LA JOLLA PHARMACEUTICAL COMPANY | Chief Operating Officer | 01/01/2019 |
Precedenti posizioni note di Luke Seikkula
Società | Posizione | Fine |
---|---|---|
SPECTRUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2015 |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Corporate Officer/Principal | 01/01/2012 |
ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/2001 |
LA JOLLA PHARMACEUTICAL COMPANY | Corporate Officer/Principal | - |
Formazione di Luke Seikkula
San Diego State University | Masters Business Admin |
Winona State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ABBOTT LABORATORIES | Health Technology |
SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 2 |
---|---|
La Jolla Pharmaceutical Co.
La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Health Technology |